Hologic Increases Bets In Lab Space With $3.7 Bil. Gen-Probe Purchase
This article was originally published in The Gray Sheet
Executive Summary
Lab diagnostic products will actually account for a larger portion of Hologic’s business post-acquisition than the firm’s core mammography, ultrasound and magnetic resonance imaging offerings.
You may also be interested in...
Blood Brothers No More: Hologic Unloads Blood-Screening Business To Partner Grifols
Hologic's partner in the blood-screening business, Grifols SA, will buy-out Hologic's share for $1.85bn. Grifols already owns all the customer-facing parts of the business; it will now take on research, development and manufacture of assays and instruments based on nucleic acid testing for transfusion and transplantation screening.
People Briefs: Ortho Clinical, Thoratec, Pentax Medical, Vygon
Ortho Clinical Diagnostics names new board members. Thoratec appoints president, International. Pentax Medical taps new CMO, COO. Vygon Group appoints VP of research & development.
People In Brief
New appointments at Hologic, Glooko and Conceptus.